🇺🇸 FDA
Pipeline program

Aramchol free acid

Aramchol-018

Phase 3 small_molecule on_hold

Quick answer

Aramchol free acid for Nonalcoholic Steatohepatitis (NASH) is a Phase 3 program (small_molecule) at Galmed Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
Galmed Pharmaceuticals
Indication
Nonalcoholic Steatohepatitis (NASH)
Phase
Phase 3
Modality
small_molecule
Status
on_hold

Clinical trials